Skip to content

Subretinal Injection of Amphotericin B Using a 41-gauge Needle for Refractory Candida albicans Subretinal Abscess

Subretinal Injection of Amphotericin B Using a 41-gauge Needle for Refractory Candida albicans Subretinal Abscess

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128522
Enrollment
Unknown
Registered
2026-07-22
Start date
2026-07-22
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

endogenous endophthalmitis,subretinal abscess

Interventions

Subretinal injection group:None

Sponsors

Hangzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age 18-80 years old; 2. Patients with subretinal abscess caused by Candida albicans infection and whose repeated vitreous drug injections are ineffective;

Exclusion criteria

Exclusion criteria: 1.Patients allergic to amphotericin B; 2.Patients whose systemic condition cannot tolerate vitrectomy;

Design outcomes

Primary

MeasureTime frame
Changes in the size of a subretinal abscess;Inflammation control status (vitreous haze, anterior chamber flare, KP absorption);

Secondary

MeasureTime frame
Best corrected vision (LogMAR or Snellen);

Countries

China

Contacts

Public ContactDing Wenting

Hangzhou First People's Hospital

315011070@qq.com+86 571 5600 5600

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026